Andrew Hill Investment Advisors, Inc. Vertex Pharmaceuticals Inc Transaction History
Andrew Hill Investment Advisors, Inc.
- $121 Million
- Q4 2024
A detailed history of Andrew Hill Investment Advisors, Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Andrew Hill Investment Advisors, Inc. holds 6,554 shares of VRTX stock, worth $3.03 Million. This represents 2.18% of its overall portfolio holdings.
Number of Shares
6,554
Previous 8,889
26.27%
Holding current value
$3.03 Million
Previous $4.13 Million
36.16%
% of portfolio
2.18%
Previous 3.31%
Shares
6 transactions
Others Institutions Holding VRTX
# of Institutions
1,732Shares Held
227MCall Options Held
1.65MPut Options Held
1.32M-
Capital World Investors Los Angeles, CA28.3MShares$13.1 Billion1.8% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.3MShares$10.8 Billion0.17% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$9.86 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.8MShares$5.47 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA10.4MShares$4.82 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $119B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...